Fexofenadine 120 mg/d vs placebo (1‐week intervention)
Secondary outcome 1. Mean change in physician‐assessed clinical signs This outcome was assessed as investigator‐assessed change in the ratio of pruritus area to body surface area · adults with eczema
1 finding from 1 review
- Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 1 participantsModerate